Project Grant R35GM162099
- Federal Project Grant Award Summary The Mount Desert Island Biological Laboratory (MDIBL) received a $432,543 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through July 31, 2030. The award funds the Emerging Leaders in Regenerative Biology and Development (REBILD) program, designed to address the critical workforce shortage in regenerative and developmental biology...
- Federal Project Grant Award Summary The Marine Biological Laboratory (MBL) received a $471,625 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 15, 2026, through February 28, 2031. This award funds fundamental basic research investigating Wnt pathway activation mechanisms using sea star oocytes as a cellular model system. The research focuses on characterizing the...
- Federal Grant Award Summary The Marine Biological Laboratory (MBL) in Woods Hole, Massachusetts, received a $471,625 Project Grant awarded August 1, 2025, through the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859). The award, with a completion date of May 31, 2030, funds fundamental research investigating the mechanisms controlling epithelial tube development, orientation, and integrity. The research employs the sea star...
- Federal Project Grant Summary The Mount Desert Island Biological Laboratory received a $422,500 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through January 31, 2031. This award funds research into the molecular mechanisms of limb and tail regeneration in axolotls, with the ultimate goal of enabling development of novel strategies for scarless tissue regeneration in...
- Federal Project Grant Award Summary Carnegie Institution for Science received a $335,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 9, 2025, with a completion date of August 31, 2026. The award funds fundamental research investigating the mechanisms by which lamins—Type V intermediate filament nuclear proteins—regulate three-dimensional (3D) genome organization and gene...
- Federal Project Grant Award Summary Baylor College of Medicine received a $440,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded February 13, 2026, with a completion date of December 31, 2030. The award supports fundamental research investigating the composition-dependent control of nucleoli and nucleolar-derived condensates in eukaryotic cells. The principal investigator's...
- Federal Grant Award Summary Rockefeller University received a $395,499 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded April 1, 2026, with completion targeted for February 28, 2031. The research focuses on elucidating cytoskeletal force-sensing mechanisms and mechanotransduction—the cellular processes by which mechanical signals from the environment are converted into biochemical...
- Federal Project Grant Award Summary The Jackson Laboratory received a $506,000 Project Grant award dated March 1, 2026, from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The project, titled "Decoding the Interplay Between QKI and M7G Methylation on 3'UTR," will be conducted at the Jackson Laboratory's Farmington, Connecticut facility through December 31, 2030. This award supports fundamental...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $431,656 Project Grant to the University of Massachusetts (Amherst, MA) effective August 1, 2025, through June 30, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). The award supports fundamental research to elucidate the function and composition of ribonucleoprotein (RNP) condensates in living cells. The research program develops and applies novel molecular...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Johns Hopkins University a Project Grant totaling $776,042 (award date: May 1, 2025; completion date: February 28, 2030) under the Biomedical Research and Research Training program (CFDA 93.859) to support research investigating the roles of microRNAs (miRNAs) in animal development. The research program systematically examines how conserved miRNAs regulate gene expression during embryonic...
The Mount Desert Island Biological Laboratory received a $464,750 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 15, 2026, with completion targeted for January 31, 2031. The award funds fundamental research exploring tissue-specific mechanisms and requirements for nucleolin (NCL) organization in living organisms, with a focus on understanding how this RNA binding protein is organized within the nucleolus and its critical role in ribosome biogenesis. The project leverages C. elegans as a model organism, utilizing advanced genetic engineering techniques including CRISPR/Cas9 technology and super-resolution imaging (Airyscan) to visualize and map sub-nucleolar organization in living cells—research that was previously limited to in vitro studies. The research deliverables include in vivo studies of nucleolin organization mechanisms in a living animal model, comprehensive mapping of sub-nucleolar architecture in germ cells, and investigation of how nucleolin disruption affects cellular processes such as fertility and development. By conducting this research in a living organism rather than cell culture systems, the project aims to clarify the biological mechanisms regulating nucleolin organization and advance understanding of how its disorganization contributes to human disease. This fundamental research is expected to establish a knowledge foundation that informs future diagnostic and therapeutic development in disease areas associated with nucleolin dysfunction.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $464.8k | 3/10/26 |